NCT06623526View on ClinicalTrials.gov

Clinical Trial to Evaluate the PK Interactions of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 4, 2024

Primary Completion Date

November 6, 2024

Study Completion Date

November 11, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

YHR2402

Test Drug: YHR2402

DRUG

YHR2402+YHR2403

Test Drug: YHR2402+YHR2403

Trial Locations (1)

Unknown

Jeonbuk National University Hospital, Jeonju

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT06623526 - Clinical Trial to Evaluate the PK Interactions of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy Volunteers | Biotech Hunter | Biotech Hunter